Teveten: profile and news

Kos Reports Continued Double Digit Increase in Revenue, Financial ...  May 9, 2006
Revenues for Kos' hypertension portfolio, comprised of Teveten(R),Teveten HCT and Cardizem(R)LA, totaled $31.6 million, excluding a $1.6million reduction in ... - Finanzen.net,

Kos Pharma Slips To Loss In Q1 On Costs; To Buy Back Up To 7 ...  May 9, 2006
The hypertension portfolio, comprising Teveten, Teveten HCT and CardizemLA, totaled $31.6 million, excluding a $1.6 million reduction in wholesaler inventories ... - Trading Markets,

Biovail Reports First-Quarter 2006 Financial Results; Company ...  May 11, 2006
Inc. (Kos), which included the divestiture of the Teveten line of products. ... 2005. Biovail no longer has an economic interest in Teveten. ... - Genetic Engineering News,

Biovail Q1 Earnings Surge On Strong Sales Of Antidepressant ...  May 11, 2006
...(KOS | charts | news | PowerRating), which included the divestiture of the Teveten line of products. ... Biovail no longer has an economic interest in Teveten. ... - Trading Markets,

CORRECTING and REPLACING Kos Announces Presentation at the Bank of ...  May 5, 2006
...the treatment of cholesterol disorders, Azmacort(R) forthe treatment of asthma, Cardizem(R)LA for the treatment ofhypertension and angina, and Teveten(R) and ... - Finanzen.net,

Kos and SkyePharma Sign Exclusive License Agreement for the ...  May 7, 2006
...for the treatment of cholesterol disorders, Azmacort forthe treatment of asthma, Cardizem(R)LA for the treatment ofhypertension and angina, and Teveten(R) and ... - Finanzen.net,

SkyePharma and Kos Announce Exclusive Licence Agreement for ...  May 7, 2006
...treatment of cholesterol disorders, Azmacort for the treatment of asthma, Cardizem® LA for the treatment of hypertension and angina, and Teveten® and Teveten ... - Yahoo! News (press release)

Kos and SkyePharma Sign Exclusive License Agreement for the ...  May 7, 2006
...the treatment of cholesterol disorders, Azmacort for the treatment of asthma, Cardizem(R)LA for the treatment of hypertension and angina, and Teveten(R) and ... - Business Wire (press release),